After the coronavirus outbreak, it looked that the primary market was down in the dumps but with the smart recovery by Indian shares following the March crash and the gradual easing of the lockdown, the launch of Rossari Biotech public offer in July ushered the IPO season in earnest. After the successful launch of SBI Card, Rossari Biotech launched an IPO in March but then cancelled it. It was also the first company to kick off the IPO season in July amid COVID-19 crisis. The overwhelming response to the Rossari Biotech IPO saw others take the plunge and the rest of the year was busy. The year 2021 is also likely to be strong, given the big line up of IPOs and expected strong market conditions along with economic and earnings recovery, experts said.

(Moneycontrol)